# Ginkgo Bioworks funds Access Bio's rapid antigen test manufacturing expansion in New Jersey

Ginkgo Bioworks provided capital to expand manufacturing capacity at Access Bio's New Jersey factory for production of rapid diagnostic tests, and secured access to at least 10 million rapid antigen test kits.

- Type: Expansion
- Announced: 2020-11-20
- Where: New Jersey, United States
- Status: announced
- Products: rapid antigen test kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Access Bio](https://endata.com/companies/51359.md)
- [Ginkgo Bioworks](https://endata.com/companies/17713.md) (investor)

## Sources

- [biospace.com](https://www.biospace.com/ginkgo-bioworks-funds-expansion-of-rapid-antigen-test-manufacturing-with-access-bio-in-new-jersey), 2020-11-20: "Ginkgo provided capital to expand manufacturing capacity at Access Bio's New Jersey factory for production of rapid diagnostic tests."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.